| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 29 Jan 2025 | 22 Jan 2025 |
| Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2025 inter alia to consider and approve 1.Approval of the unaudited standalone financial result for the quarter ended December 31 2024 along with Limited Review Report as received from the statutory auditors of the company Unaudited Financial results for the quarter ended 31st December, 2024 Outcome of Board meeting held today ie 29th January, 2025 (As per BSE Announcement Dated on 29/01/2025) | ||
| Board Meeting | 19 Nov 2024 | 19 Nov 2024 |
| Pursuant to Regulation 30 read with schedule III of SEBI (LODR) Regulation 2015. we wish to inform that the Board of Directors of the Company at the meeting held today, based on the recommendation of the NRC and subject to approval of the shareholders of the Company, have unanimously approved: 1. Reappointment of the following Independent Directors for a period of 5 years: Mr. Girish P Vanvari, Ms. Divya Sameer Momaya, Ms.Preeti G Mehta. 2. Appointment of Independent Director Ms. Priyanka Yadav 3. Appointment of Mr. Popat Kedar as an Executive Director. | ||
| Board Meeting | 29 Oct 2024 | 23 Oct 2024 |
| Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve the Unaudited Standalone Financial Results for the Quarter and Half Year ended 30th September 2024 along with Limited Review Report as received from the statutory auditors of the company. Approval of Unaudited Standalone Financial Results for the half year and quarter ended September 30, 2024 along with Limited Review Report as received from the statutory auditor of the company (As Per BSE Announcement dated on 29.10.2024) | ||
| Board Meeting | 6 Aug 2024 | 31 Jul 2024 |
| Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2024 inter alia to consider and approve Approval of the Unaudited Standalone Financial Results for the quarter ended June 30 2024 along with Limited Review Report from the Statutory Auditor of the Company. Unaudited Financial Statement for the Quarter ended June 30, 2024 along with LRR as received from Statutory Auditors (As Per BSE Announcement dated on 06.08.2024) | ||
| Board Meeting | 25 May 2024 | 17 May 2024 |
| Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 inter alia to consider and approve Pursuant to Regulation 29 and 33 of SEBI LODR Regulations 2015 we hereby inform you that the meeting of Board of directors of Bluejet Healthcare Limited is scheduled to be held on Saturday 25th May 2024 to inter alia consider the Following: 1. Approval of Audited Standalone Financial Results for the quarter and financial year ended 31st March 2024 along with audited report thereon. 2. To consider recommending final dividend on the equity shares of the Company for the financial year ended 31st March 2024 if any subject to the approval of the shareholders at the ensuring Annual General Meeting. Outcome of Board Meeting for the fourth quarter and financial year ended 31st March 2024. (As per BSE Announcement Dated on 25/05/2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
